Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 53

Sort by

Sort Order Select

Journal Articles

Association of Community-Level Socioeconomic Distress with Nutritional Status in People with Sickle Cell Anemia

Syeda Akila Ally, Jin Han, Robert E. Molokie, James P. Lash, Victor R. Gordeuk, Santosh L. Saraf

Blood (2022) 140 (Supplement 1): 8280–8281.

https://doi.org/10.1182/blood-2022-159081

Published: 2022

Journal Articles

Reticulocytosis from Stress Erythropoiesis Is a Major Source of Erythrocyte Mitochondrial Retention, Oxygen Consumption and Reactive Oxygen Species in a SCD Mouse Model

Anne Gallivan, Amarachi Kanu, Mikail Alejandro, Nebeyat Zekaryas, Hart Horneman, Jagadeesh Ramasamy, Lenny Hong, Donald Lavelle, Alan Diamond, Robert E. Molokie, Elliott P. Vichinsky, Angela Rivers

Blood (2022) 140 (Supplement 1): 8239–8240.

https://doi.org/10.1182/blood-2022-160481

Published: 2022

Journal Articles

COVID-19 Vaccination Status and Disease Burden in Patients with Sickle Cell Disease

Jin Han, Xu Zhang, Robert E. Molokie, Franklin Njoku, Faiz Ahmed Hussain, Marwah Farooqui, Insia Rizvi, Santosh L. Saraf, Victor R. Gordeuk

Blood (2022) 140 (Supplement 1): 5027–5028.

https://doi.org/10.1182/blood-2022-166597

Published: 2022

Journal Articles

Prolonged Combinatorial Pharmacological Therapy Targeting the Epigenome Increases Fetal Hemoglobin to Clinically Relevant Levels in Normal, Nonanemic Baboons

Vinzon Ibanez, Kestis Vaitkus, Robert E. Molokie, Jagadeesh Ramasamy, Yogenthiran Saunthararajah, Donald Lavelle

Blood (2022) 140 (Supplement 1): 961–962.

https://doi.org/10.1182/blood-2022-155954

Published: 2022

Journal Articles

Effect of the NAMPT Activator P7C3-A20 on γ-Globin Expression in Baboon CD34+ Erythroid Cell Cultures

Vinzon Ibanez, Kestis Vaitkus, Jagadeesh Ramasamy, Yogenthiran Saunthararajah, Robert E. Molokie, Donald Lavelle

Blood (2021) 138 (Supplement 1): 961.

https://doi.org/10.1182/blood-2021-145126

Published: 2021

Journal Articles

Clinical and Biomarker Predictors for Avascular Necrosis in Sickle Cell Disease

Michael Rabaza, Maria Armila Ruiz, Liana Posch, Faiz Ahmed Hussain, Franklin Njoku, Robert E. Molokie, Jin Han, Victor R. Gordeuk, Karen Xie, Santosh L. Saraf

Blood (2021) 138 (Supplement 1): 3091.

https://doi.org/10.1182/blood-2021-147829

Published: 2021

Journal Articles

Naloxone Use for Opioid Reversal in Patients with Sickle Cell Disease

Mahir Khan, Jin Han, Santosh L. Saraf, Robert E. Molokie

Blood (2021) 138 (Supplement 1): 2038.

https://doi.org/10.1182/blood-2021-145658

Published: 2021

Journal Articles

Nicotinamide Improves Anemia and Decreases Reactive Oxygen Species in Sickle Cell Disease Mice

Jagadeesh Ramasamy, Vinzon Ibanez, Vijaya Lakshmi Yalagala, Yogenthiran Saunthararajah, Robert E. Molokie, Angela Rivers, Donald Lavelle

Blood (2021) 138 (Supplement 1): 2019.

https://doi.org/10.1182/blood-2021-144956

Published: 2021

Journal Articles

Defining and Predicting Rapid Egfr Decline in Sickle Cell Disease

Santosh L. Saraf, Jin Han, Maria Armila Ruiz, Andrew Srisuwananukorn, David Shuey, Faiz Ahmed Hussain, Franklin Njoku, Robert E. Molokie, Victor R. Gordeuk

Blood (2021) 138 (Supplement 1): 122.

https://doi.org/10.1182/blood-2021-147861

Published: 2021

Journal Articles

Lower Apache II Score and Exchange Transfusions Predict Better Outcomes in the Intensive Care Unit for Patients with Sickle Cell Disease

Renee Cheng, MD, Andrew Srisuwananukorn, MD, Jin Han, Michel Gowhari, DO, Franklin Njoku, MD, Faiz Ahmed Hussain, MD, Robert E. Molokie, MD, Victor R. Gordeuk, MD, Santosh L. Saraf, MD

Blood (2020) 136 (Supplement 1): 18–19.

https://doi.org/10.1182/blood-2020-137272

Published: 2020

Journal Articles

Combinatorial Administration of Pharmacological Inhibitors Targeting DNMT1 and KDM1A Produces Synergistic and Additive Increases in F Retiulocytes and γ-Globin Expression in Normal Baboons

Vinzon Ibanez, B.S., Kestis Vaitkus, Robert E. Molokie, MD, Yogenthiran Saunthararajah, MD, Donald Lavelle, PhD

Blood (2020) 136 (Supplement 1): 5.

https://doi.org/10.1182/blood-2020-136599

Published: 2020

Journal Articles

Complications in Pregnancy of Sickle Cell Disease

Avani Singh, MD, Conner Olsen, MD, Xu Zhang, PhD, Robert E. Molokie, MD

Blood (2020) 136 (Supplement 1): 32–33.

https://doi.org/10.1182/blood-2020-138470

Published: 2020

Journal Articles

Cathepsin B, a Negative Regulator of Autophagy, Identified As a Novel Therapeutic Drug Target in Sickle Cell Disease

Jagadeesh Ramasamy, PhD, Vinzon Ibanez, B.S., Kareem Al-Qadi, Helen Zhang, Jennifer Afranie-Sakyi, MD, Robert E. Molokie, MD, Donald Lavelle, PhD, Angela Rivers, MD

Blood (2020) 136 (Supplement 1): 32.

https://doi.org/10.1182/blood-2020-140119

Published: 2020

Journal Articles

Outcomes in Vaso-Occlusive Crisis Treatment in the Emergency Department Vs. Acute Care Observation Center

Renee Cheng, MD, Avani Singh, MD, Xu Zhang, PhD, Priyanka Nasa, Jin Han, Doris Alfaro, Laura Kavoliunaite, Chika Nwachukwu, CNP, Karen Woodard, Robert E. Molokie, MD, Victor R. Gordeuk, MD, Michel Gowhari, DO

Blood (2020) 136 (Supplement 1): 22–23.

https://doi.org/10.1182/blood-2020-137297

Published: 2020

Journal Articles

Correction of Point-of-Care International Normalized Ratio (INR) Values in Patients with Sickle Cell Disease

Syeda Rahman, Andrew Srisuwananukorn, MD, Robert E. Molokie, MD, Michel Gowhari, DO, Franklin Njoku, MD, Faiz Ahmed Hussain, MD, Edith A. Nutescu, PharmD., MS, FCCP, Victor R. Gordeuk, MD, Santosh L. Saraf, MD, Jin Han

Blood (2020) 136 (Supplement 1): 34–35.

https://doi.org/10.1182/blood-2020-137166

Published: 2020

Journal Articles

Effects of Hydroxyurea and Renin-Angiotensin Blockade on Kidney Function in Sickle Cell Disease

Jin Han, Andrew Srisuwananukorn, MD, Michel Gowhari, DO, Faiz Ahmed Hussain, MD, Franklin Njoku, MD, Robert E. Molokie, MD, Victor R. Gordeuk, MD, Santosh L. Saraf, MD

Blood (2020) 136 (Supplement 1): 21–22.

https://doi.org/10.1182/blood-2020-138753

Published: 2020

Journal Articles

Cancer Incidence and Chemotherapy Tolerance in Patients with Sickle Cell Disease

Mahir Khan, MD, Andrew Srisuwananukorn, MD, Santosh L. Saraf, MD, Faiz Ahmed Hussain, MD, Robert E. Molokie, MD, Michel Gowhari, DO, Victor R. Gordeuk, MD, Franklin Njoku, MD

Blood (2020) 136 (Supplement 1): 24–25.

https://doi.org/10.1182/blood-2020-139653

Published: 2020

Journal Articles

Effect of Nicotinamide, 1-Methylnicotinamide, and N'-Methylnicotinamide on Erythroid Colony Formation and γ-Globin Expression in Cultured Baboon CD34+ Cells

Donald Lavelle, PhD, Vinzon Ibanez, B.S., Kestis Vaitkus, Yogenthiran Saunthararajah, MD, Robert E. Molokie, MD

Blood (2020) 136 (Supplement 1): 4–5.

https://doi.org/10.1182/blood-2020-133974

Published: 2020

Journal Articles

Risk Factors for Kidney Disease in Hb SC and Hb Sβ + -Thalassemia Sickle Cell Disease

Mandella Mensah, Binal N. Shah, Xu Zhang, PhD, Jin Han, PharmD, PhD, Michel Gowhari, DO, Robert E. Molokie, MD, Mark T Gladwin, MD, Victor R Gordeuk, MD, Santosh L. Saraf, MD

Blood (2019) 134 (Supplement_1): 2299.

https://doi.org/10.1182/blood-2019-128668

Published: 2019

Journal Articles

Impact of Intravenous Opioid Shortage on Managing Pain Crisis in Sickle Cell Disease

Jin Han, PharmD, PhD, Santosh L. Saraf, MD, Michel Gowhari, DO, Faiz Ahmed Hussain, MD, Shivi Jain, MD, Laura Kavoliunaite, APN, Robert E. Molokie, MD, Victor R Gordeuk, MD

Blood (2019) 134 (Supplement_1): 3390.

https://doi.org/10.1182/blood-2019-122249

Published: 2019

NARROW

Association of Community-Level Socioeconomic Distress with Nutritional Status in People with Sickle Cell Anemia

Reticulocytosis from Stress Erythropoiesis Is a Major Source of Erythrocyte Mitochondrial Retention, Oxygen Consumption and Reactive Oxygen Species in a SCD Mouse Model

COVID-19 Vaccination Status and Disease Burden in Patients with Sickle Cell Disease

Prolonged Combinatorial Pharmacological Therapy Targeting the Epigenome Increases Fetal Hemoglobin to Clinically Relevant Levels in Normal, Nonanemic Baboons

Effect of the NAMPT Activator P7C3-A20 on γ-Globin Expression in Baboon CD34+ Erythroid Cell Cultures

Clinical and Biomarker Predictors for Avascular Necrosis in Sickle Cell Disease

Naloxone Use for Opioid Reversal in Patients with Sickle Cell Disease

Nicotinamide Improves Anemia and Decreases Reactive Oxygen Species in Sickle Cell Disease Mice

Defining and Predicting Rapid Egfr Decline in Sickle Cell Disease

Lower Apache II Score and Exchange Transfusions Predict Better Outcomes in the Intensive Care Unit for Patients with Sickle Cell Disease

Combinatorial Administration of Pharmacological Inhibitors Targeting DNMT1 and KDM1A Produces Synergistic and Additive Increases in F Retiulocytes and γ-Globin Expression in Normal Baboons

Complications in Pregnancy of Sickle Cell Disease

Cathepsin B, a Negative Regulator of Autophagy, Identified As a Novel Therapeutic Drug Target in Sickle Cell Disease

Outcomes in Vaso-Occlusive Crisis Treatment in the Emergency Department Vs. Acute Care Observation Center

Correction of Point-of-Care International Normalized Ratio (INR) Values in Patients with Sickle Cell Disease

Effects of Hydroxyurea and Renin-Angiotensin Blockade on Kidney Function in Sickle Cell Disease

Cancer Incidence and Chemotherapy Tolerance in Patients with Sickle Cell Disease

Effect of Nicotinamide, 1-Methylnicotinamide, and N'-Methylnicotinamide on Erythroid Colony Formation and γ-Globin Expression in Cultured Baboon CD34+ Cells

Risk Factors for Kidney Disease in Hb SC and Hb Sβ + -Thalassemia Sickle Cell Disease

Impact of Intravenous Opioid Shortage on Managing Pain Crisis in Sickle Cell Disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only